Changing the FDA Approval Process

Talk by Susan Desmond-Hellmann, Chancellor of UCSF

Share:

Uploaded by Essinova on March 21, 2011

This video is an excerpt of the speaker's talk for the Entrepreneurial Thought Leaders Lecture Series at Stanford University.

Susan Desmond-Hellmann, chancellor of UCSF, has a big idea to change the drug approval process at the Food and Drug Administration (FDA). The current process is binary, allowing for only a yes or no from the reviewer for drug approval. Desmond-Hellmann suggests that a variable approval process, that can change status as greater evidence comes in over time, will encourage more innovative products and even investment funding, based on product confidence.

Tags: Susan Desmond-Hellmann, UCSF, FDA

RELATED

COMMENTS

There are 0 comments. You must be logged in to comment.

Opinions & Expertise

 photo Essinova-Brain-and-Mind-banner_iStock_000004422514Medium.jpg

 photo Essinova_Art-and-Science-banner_PIA09962.jpg